Macquarie Group LTD Masimo Corp Transaction History

Macquarie Group LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 21, 2023	SELL	$110.88 - $150.36 $47,234 - $64,053	-426 Reduced 9.36%	4,126 $610,000
Q3 2022 Nov 14, 2022	SELL	$125.58 - $169.38 $74,092 - $99,934	-590 Reduced 11.47%	4,552 $642,000
Q1 2022 May 16, 2022	SELL	$135.71 - $284.87 $64.9 Million - $136 Million	-477,860 Reduced 98.94%	5,142 $749,000
Q4 2021 Feb 11, 2022	SELL	$266.41 - $303.29 $21.5 Million - $24.5 Million	-80,757 Reduced 14.32%	483,002 $141 Million
Q3 2021 Nov 12, 2021	SELL	$249.0 - $285.24 $806,013 - $923,321	-3,237 Reduced 0.57%	563,759 $153 Million
Q2 2021 Aug 13, 2021	BUY	$208.49 - $248.2 $118 Million - $140 Million	563,611 Added 16650.25%	566,996 $137 Million
Q1 2021 May 14, 2021	BUY	$220.31 - $283.75 $124,475 - $160,318	565 Added 20.04%	3,385 $778,000
Q3 2020 Nov 13, 2020	BUY	$209.49 - $246.81 $181,627 - $213,984	867 Added 44.39%	2,820 $666,000
Q2 2020 Aug 11, 2020	SELL	$178.49 - $250.39 $211,867 - $297,212	-1,187 Reduced 37.8%	1,953 $446,000
Q1 2020 May 15, 2020	BUY	$148.38 - $186.78 $273,019 - $343,675	1,840 Added 141.54%	3,140 $556,000
Q4 2019 Feb 14, 2020	SELL	$140.81 - $159.49 $211,215 - $239,235	-1,500 Reduced 53.57%	1,300 $205,000
Q2 2019 Aug 14, 2019	BUY	$122.29 - $148.82 $342,412 - $416,696	2,800 New	2,800 $417,000
Q1 2018 May 11, 2018	SELL	$82.06 - $95.19 $90,266 - $104,709	-1,100 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$84.49 - $90.09 $388,654 - $414,414	-4,600 Reduced 80.7%	1,100 $93,000
Q3 2017 Nov 08, 2017	BUY	$81.79 - $96.62 $466,203 - $550,734	5,700	5,700 $493,000

403

43.3M

310K

268K

Ticker MASI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 52,530,200
Market Cap $9.15B
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximet...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.